Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5206170
Max Phase: Preclinical
Molecular Formula: C18H20N6O2S
Molecular Weight: 384.47
Associated Items:
ID: ALA5206170
Max Phase: Preclinical
Molecular Formula: C18H20N6O2S
Molecular Weight: 384.47
Associated Items:
Canonical SMILES: CC(C)Oc1ccc(-c2nsc(Nc3ncccc3C(=O)N(C)C)n2)nc1
Standard InChI: InChI=1S/C18H20N6O2S/c1-11(2)26-12-7-8-14(20-10-12)16-22-18(27-23-16)21-15-13(6-5-9-19-15)17(25)24(3)4/h5-11H,1-4H3,(H,19,21,22,23)
Standard InChI Key: GMXCIXHDDDRDMB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 384.47 | Molecular Weight (Monoisotopic): 384.1368 | AlogP: 3.23 | #Rotatable Bonds: 6 |
Polar Surface Area: 93.13 | Molecular Species: ACID | HBA: 8 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.79 | CX Basic pKa: 0.92 | CX LogP: 4.18 | CX LogD: 2.67 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.70 | Np Likeness Score: -2.05 |
1. Hawryluk N, Robinson D, Shen Y, Kyne G, Bedore M, Menon S, Canan S, von Geldern T, Townson S, Gokool S, Ehrens A, Koschel M, Lhermitte-Vallarino N, Martin C, Hoerauf A, Hernandez G, Dalvie D, Specht S, Hübner MP, Scandale I.. (2022) Discovery of Substituted Di(pyridin-2-yl)-1,2,4-thiadiazol-5-amines as Novel Macrofilaricidal Compounds for the Treatment of Human Filarial Infections., 65 (16.0): [PMID:35972896] [10.1021/acs.jmedchem.2c00960] |
Source(1):